OVID Earnings

Quarterly EPS
$-0.20
Q3 2024
$-0.13
Q4 2024
$-0.14
Q1 2025
$-0.06
Q2 2025
$-0.17
Q3 2025
$0.12
Q4 2025
$-0.12
Q1 2026
$-0.08
Q2 2026
Latest Revenue733.0K
Latest Net Income-15009000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.08733.0K-15009000-88.3%-33.3%
Q1 2026-$0.120-16988000-100.0%+14.3%
Q4 2025$0.12718.0K9.7M+844.7%+192.3%
Q3 2025-$0.17132.0K-12158000-23.7%+15.0%
Q2 2025-$0.066.3M-4684000+3,611.2%-150.0%
Q1 2025-$0.14130.0K-10235000-12.2%+17.6%
Q4 2024-$0.1376.0K-9253000-46.5%+40.9%
Q3 2024-$0.20173.0K-14006000+58.7%-25.0%
Q2 2024$0.12169.0K8.5M
Q1 2024-$0.17148.0K-11694000
Q4 2023-$0.22142.0K-15322000
Q3 2023-$0.16109.0K-11253000
Ovid Therapeutics (OVID) — Earnings